Coloplast A/S provided earnings guidance for Fiscal year 2023-2024. For the year company expects, organic revenue growth of around 8% and an EBIT margin of 27%-28%.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
833.3 DKK | -0.89% | +3.30% | +7.98% |
06-06 | Transcript : Coloplast A/S - Analyst/Investor Day | |
05-15 | COLOPLAST : Multiple silver linings in spite of a soft Q2 24 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.98% | 27.39B | |
-41.00% | 2.63B | |
+26.30% | 2.48B | |
-23.19% | 2.31B | |
+5.99% | 2.21B | |
+24.44% | 1.91B | |
+33.51% | 1.34B | |
+27.17% | 1.32B | |
+1.64% | 1.25B | |
+31.91% | 1.04B |
- Stock Market
- Equities
- COLO B Stock
- News Coloplast A/S
- Coloplast A/S Provides Earnings Guidance for Fiscal Year 2023-2024